COVID-19 vaccine effectiveness dropped to 66% against delta, CDC finds
But health professionals say you should still get vaccinated.
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
The delta variant has dealt a blow to COVID-19 vaccine effectiveness, which has dropped by about 25 percentage points since the variant became the dominant strain of coronavirus in the U.S., a new study among healthcare workers finds.
The study, from the Centers for Disease Control and Prevention (CDC), found that the vaccines' effectiveness against COVID-19 infections declined from 91% prior to the delta variant's emergence, to 66% after the rise of the delta variant in the summer.
Despite this "moderate reduction," health officials stressed that "the sustained two-thirds reduction in infection risk underscores the continued importance and benefits of COVID-19 vaccination," the authors wrote in the study, published Tuesday (Aug. 24) in the CDC journal Morbidity and Mortality Weekly Report (MMWR).
Related: How deadly is the coronavirus delta variant?
The study is based on information from more than 4,000 health care workers in six U.S. states (Arizona, Florida, Minnesota, Oregon, Texas and Utah), from mid-December 2020 through mid-August 2021. During the study period (both before and after the rise of the delta variant), the effectiveness of COVID-19 vaccines against infection was 80%, the study found.
Eight-three percent of healthcare workers in the study were vaccinated; 65% had received the Pfizer-BioNTech vaccine, 33% had received the Moderna vaccine and 2% had received the Johnson & Johnson vaccine.
The researchers say their finding showing a decline in vaccine effectiveness after the rise of delta should be interpreted with caution, because vaccine effectiveness may also be declining as a result of the increased time since people were vaccinated. In other words, people's immunity may have waned somewhat with the passage of time, rather than just as the result of a new variant.
Get the world’s most fascinating discoveries delivered straight to your inbox.
The study also did not examine the severity of the infections. But a second CDC study, also published Tuesday in MMWR, did examine severity by looking at the rate of hospitalizations for COVID-19 among vaccinated and unvaccinated people in Los Angeles.
This second study, which examined more than 43,000 COVID-19 infections among L.A. residents from May 1 through July 25, 2021, found that 71.4% of infections were among unvaccinated people, 25.3% of infections were among fully vaccinated people and 3.3% of infections were among partially vaccinated people. At the end of the study period, the COVID-19 infection rate among unvaccinated people was nearly 5 times higher, and the hospitalization rate nearly 30 times higher, than the rate among fully vaccinated people.
"These infection and hospitalization rate data indicate that authorized vaccines were protective against SARS-CoV-2 infection and severe COVID-19 during a period when transmission of the delta variant was increasing," the authors wrote. "Efforts to increase COVID-19 vaccination, in coordination with other prevention strategies, are critical to preventing COVID-19-related hospitalizations and deaths."
Originally published on Live Science.

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.
